Watch KAPA. Know when insiders buy.
One email the day a filing lands. Free.
KAPA
Kairos Pharma, LTD.
0.53
+0.02 +4.75%
USD · close Nov 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
26
FLAG · shorts 26
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $12.5MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$5.8MNET CASH —52W 0.47 – 6.79SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose KAPA in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on KAPA in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.